Skip to main content
. 2021 Oct 7;5(Suppl 2):e12589. doi: 10.1002/rth2.12589
Number of reported bleeds within 12 months prior to enrollment (median, Q1, Q3) Naïve to damoctocog alfa pegol (N = 6) Pre‐treated with damoctocog alfa pegol (N = 32) Total (N = 38)
Total bleeds 4 (2.0, 10.0) 0.0 (0.0, 1.0) 0.0 (0.0, 4.0)
Spontaneous 3.5 (1.0, 10.0) 0.0 (0.0, 0.0) 0.0 (0.0, 1.0)
Trauma 0.0 (0.0, 1.0) 0.0 (0.0, 0.0) 0.0 (0.0, 1.0)
Joint 3.5 (1.0, 10.0) 0.0 (0.0, 1.0) 0.0 (0.0, 2.0)
Spontaneous joint 3.0 (1.0, 10.0) 0.0 (0.0, 1.0) 0.0 (0.0, 1.0)
Trauma joint 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
Note: Patients were enrolled at their initial visit, at which baseline data was recorded.